Autoimmune Type 1 Diabetes Franchise Head Italy

Location: Milan, Italy; hybrid work arrangement

Salary: €99,200–€132,267 annually

Company

hirify.global is a pharmaceutical company developing and commercializing medicines for chronic and complex conditions, including autoimmune type 1 diabetes.

What you will do

• Lead the Italian launch of Teizeild for autoimmune type 1 diabetes, including the integrated growth plan, local execution, and KPI tracking.
• Develop stakeholder engagement strategies across medical, market access, public affairs, communications, healthcare providers, payers, patient groups, and scientific organizations.
• Secure optimal market access and drive treatment uptake by supporting infusion readiness and building confidence in the healthcare community.
• Shape the Italian healthcare system by accelerating screening, expanding partnerships, and improving the patient pathway from detection to treatment.
• Use AI models to identify at-risk patients and predict disease progression for earlier and more precise intervention.
• Lead and develop a best-in-class commercial organization while contributing to the GenMed Italy leadership team.

Requirements

• At least 10 years of industry experience in sales or marketing, including launch brands and disease-area shaping.
• Experience with brand planning, omnichannel strategy, sales leadership, customer centricity, execution excellence, and brand P&L ownership.
• Experience in specialty, rare disease, or type 1 diabetes environments is desirable.
• Experience leading a local brand team and building partnerships with universities, hospitals, healthcare providers, and other stakeholders.
• Deep understanding of the Italian healthcare ecosystem, with strong strategic, analytical, communication, and leadership skills.
• Strong written and verbal communication skills in English and Italian are required.

Nice to have

• Experience in a global or regional role above the country level.
• Experience with disease-area shaping, omnichannel engagement, and immunotherapy or diabetes innovation.

Culture & Benefits

• Opportunity to shape the future of care for chronic and complex conditions.
• Work on medicines reaching more than 100 million people annually.
• Participation in a digital- and AI-powered business transformation.
• Equal-opportunity workplace with a focus on diversity and inclusion.